South Africa Must Revoke Key COVID-19 Patents, Says MSF

Eli Lilly Baricitinib Patent Is Limiting Access To Affordable Generics

 
• By Chloe Kent
  
Eli Lilly world headquarters
MSF says Eli Lilly's baricitinib patent is unfairly blocking access to the drug in South Africa • Source: Alamy

More from Legal & IP

More from Generics Bulletin